ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,537
Screening encounters
2,803
Diagnostic referrals
540
Outstanding pathways
216

Screening pathway

  1. Screening2,803Encounters
  2. Positive finding945Documented findings
  3. Referral540Diagnostic referrals
  4. Follow-up626Diagnostic visits
  5. Outcome324Resolved pathways

Stage totals use different units. Pending pathways: 216. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 4233 · EXP-4233Synthetic · Site D

Full participant history through 2026-03-27, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-06-06
  4. · Diagnostic referral · EXP-4233-T-R
  5. · Contact attempt · Reached
  6. · Barrier documented · Transport difficulty
  7. · Diagnostic booking · Initial booking
  8. · Diagnostic visit · Attended
  9. · Diagnosis · Colposcopy · Biopsy collected
  10. · Diagnosis · Histopathology · No high-grade lesion identified
  11. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-01-25
  12. · Follow-up disposition · Resolved · EXP-4233-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

2537 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-4234 · Expanded synthetic participant 4234Site A — Urban Referral Hub
EXP-4235 · Expanded synthetic participant 4235Site C — Rural Outreach Programme
EXP-4239 · Expanded synthetic participant 4239Site D — Community Engagement Programme
EXP-4240 · Expanded synthetic participant 4240Site B — Peri-Urban Access Programme
EXP-4241 · Expanded synthetic participant 4241Site A — Urban Referral Hub
EXP-4242 · Expanded synthetic participant 4242Site D — Community Engagement Programme
EXP-4244 · Expanded synthetic participant 4244Site C — Rural Outreach Programme
EXP-4245 · Expanded synthetic participant 4245Site A — Urban Referral Hub
EXP-4248 · Expanded synthetic participant 4248Site A — Urban Referral Hub
EXP-4249 · Expanded synthetic participant 4249Site D — Community Engagement Programme
EXP-4250 · Expanded synthetic participant 4250Site D — Community Engagement Programme
EXP-4251 · Expanded synthetic participant 4251Site D — Community Engagement Programme
EXP-4252 · Expanded synthetic participant 4252Site E — Resource-Constrained Navigation Programme
EXP-4253 · Expanded synthetic participant 4253Site A — Urban Referral Hub
EXP-4254 · Expanded synthetic participant 4254Site A — Urban Referral Hub
EXP-4255 · Expanded synthetic participant 4255Site D — Community Engagement Programme
EXP-4256 · Expanded synthetic participant 4256Site E — Resource-Constrained Navigation Programme
EXP-4259 · Expanded synthetic participant 4259Site A — Urban Referral Hub
EXP-4260 · Expanded synthetic participant 4260Site A — Urban Referral Hub
EXP-4261 · Expanded synthetic participant 4261Site B — Peri-Urban Access Programme
EXP-4264 · Expanded synthetic participant 4264Site D — Community Engagement Programme
EXP-4267 · Expanded synthetic participant 4267Site D — Community Engagement Programme
EXP-4269 · Expanded synthetic participant 4269Site D — Community Engagement Programme
EXP-4270 · Expanded synthetic participant 4270Site A — Urban Referral Hub
EXP-4271 · Expanded synthetic participant 4271Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1162
HPV DNA
1223
Cytology
418

Navigation activity

Barrier documented
458
Contact attempt
787
Navigation intervention
193
Diagnostic booking
663
Diagnostic visit
626

Documented barriers

Contact difficulty
146
Transport difficulty
144
Appointment coordination
168

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.